| Yervoy |
125377 |
002 |
351(a) |
ipilimumab |
Injection |
Intravenous |
200MG/40ML (5MG/ML) |
Single-Dose Vial |
2011/03/25
|
Bristol-Myers Squibb Company |
Rx |
Licensed |
N/A |
N/A |
|
125296 |
001 |
351(a) |
Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
Tablet |
Oral |
4.5LOG 10TCID |
Bottle |
2011/03/16
|
Teva Women's Health, Inc. |
Rx |
Licensed |
|
N/A |
| Benlysta |
125370 |
001 |
351(a) |
belimumab |
For Injection |
Intravenous |
120MG |
Single-Dose Vial |
2011/03/09
|
GlaxoSmithKline LLC |
Rx |
Licensed |
N/A |
N/A |
| Benlysta |
125370 |
002 |
351(a) |
belimumab |
For Injection |
Intravenous |
400MG |
Single-Dose Vial |
2011/03/09
|
GlaxoSmithKline LLC |
Rx |
Licensed |
N/A |
N/A |
| Corifact |
125385 |
001 |
351(a) |
Factor XIII Concentrate (Human) |
For Injection |
Intravenous |
1000-1600IU |
Single-Dose Vial |
2011/02/17
|
CSL Behring GmbH |
Rx |
Licensed |
|
N/A |
| Thrombin-Jmi, Thrombocoll |
102865 |
002 |
351(a) |
Thrombin, Topical (Bovine) |
Powder |
Topical |
5,000IU |
Vial |
2011/02/10
|
GenTrac, Inc. |
Rx |
Licensed |
|
N/A |
| Wilate |
125251 |
001 |
351(a) |
von Willebrand Factor/Coagulation Factor VIII Complex (Human) |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
2010/12/20
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Wilate |
125251 |
002 |
351(a) |
von Willebrand Factor/Coagulation Factor VIII Complex (Human) |
For Injection |
Intravenous |
1000IU |
Single-Dose Vial |
2010/12/20
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Xgeva |
125320 |
003 |
351(a) |
denosumab |
Injection |
Subcutaneous |
120MG/1.7ML (70MG/ML) |
Single-Dose Vial |
2010/11/18
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |
| Egrifta |
022505 |
001 |
351(a) |
tesamorelin |
For Injection |
Subcutaneous |
1MG |
Single-Dose Vial |
2010/11/10
|
Theratechnologies Inc. |
Disc |
Licensed |
N/A |
N/A |
| Krystexxa |
125293 |
001 |
351(a) |
pegloticase |
Injection |
Intravenous |
8MG/ML |
Single-Dose Vial |
2010/09/14
|
Horizon Therapeutics Ireland DAC |
Rx |
Licensed |
N/A |
N/A |
| Novoseven, Novoseven Rt |
103665 |
007 |
351(a) |
Coagulation Factor VIIa (Recombinant) |
For Injection |
Intravenous |
8.0MG |
Single-Dose Vial |
2010/08/06
|
Novo Nordisk Inc. |
Rx |
Licensed |
|
N/A |
| Xyntha, Xyntha Solofuse |
125264 |
009 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free |
For Injection |
Intravenous |
3000IU |
Pre-Filled Syringe |
2010/08/06
|
Wyeth Pharmaceuticals LLC |
Rx |
Licensed |
|
N/A |
| Xeomin |
125360 |
001 |
351(a) |
incobotulinumtoxinA |
For Injection |
Intramuscular, Intraglandular |
50UNITS |
Single-Dose Vial |
2010/07/30
|
Merz Pharmaceuticals GmbH c/o Merz Pharmaceuticals LLC |
Rx |
Licensed |
N/A |
N/A |
| Xeomin |
125360 |
002 |
351(a) |
incobotulinumtoxinA |
For Injection |
Intramuscular, Intraglandular |
100UNITS |
Single-Dose Vial |
2010/07/30
|
Merz Pharmaceuticals GmbH c/o Merz Pharmaceuticals LLC |
Rx |
Licensed |
N/A |
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
006 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5G/50ML |
Single-Dose Vial |
2010/07/27
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
007 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10G/100ML |
Single-Dose Vial |
2010/07/27
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
008 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
20G/200ML |
Single-Dose Vial |
2010/07/27
|
Instituto Grifols, S.A. |
Disc |
Licensed |
|
N/A |
| Glassia |
125325 |
001 |
351(a) |
Alpha-1-Proteinase Inhibitor (Human) |
Injection |
Intravenous |
1G |
Single-Dose Vial |
2010/07/01
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Prolia |
125320 |
001 |
351(a) |
denosumab |
Injection |
Subcutaneous |
60MG/ML |
Pre-Filled Syringe |
2010/06/01
|
Amgen Inc. |
Rx |
Licensed |
N/A |
N/A |